Patent · US Active

Prevention and treatment of osteoarthritis

US8709997B2 · kind B2 · utility

0Cited by
0References
12Claims
0Family size

Assignee

Inventor

Key dates

Filing dateAug 31, 2012
Grant dateApr 29, 2014
Priority date
Expiry dateAug 31, 2032

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/105
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Subjects lacking Nfat1 display osteoarthritis in weight-bearing joints. Osteoarthritic changes associated with Nfat1 deficiency are characterized by articular cartilage degradation, articular chondrocyte proliferation/clustering, progressive articular surface destruction, periarticular chondro-osteophyte formation, and exposure of thickened subchondral bone. Methods of treating osteoarthritis, methods of diagnosis and early prediction of the onset of osteoarthritis, and methods for screening drug candidates that may be useful for treatment of osteoarthritis are presented.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.